Next Article in Journal
Strategies to Reduce Mental Illness Stigma: Perspectives of People with Lived Experience and Caregivers
Previous Article in Journal
Creativity: The Effectiveness of Teacher–Student Conflict
Previous Article in Special Issue
Societal Narratives on Caregivers in Asia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Full-Time or Working Caregiver? A Health Economics Perspective on the Supply of Care for Type 1 Diabetes Patients

Japan Society for the Promotion of Science, Kyoto University, Kyoto 606-8501, Japan
Int. J. Environ. Res. Public Health 2022, 19(3), 1629; https://doi.org/10.3390/ijerph19031629
Submission received: 16 September 2021 / Revised: 24 January 2022 / Accepted: 26 January 2022 / Published: 31 January 2022
(This article belongs to the Special Issue The Economics of Caring)

Abstract

:
Type 1 diabetes mellitus (T1DM) is a chronic disease requiring lifelong insulin treatment. T1DM patients require care given not only by themselves but also by their family members, particularly in childhood-onset cases. This study aims to identify the relationship between health expenditure, HbA1c and other health outcomes and the socio-economic status of patients and their families, with a focus on family employment status, i.e., whether the caregiver is employed or is a homemaker. To clarify the relationship between the level of health, such as expenditure on health care and HbA1c, and the socioeconomic status of patients and their families, we focus on whether they are “potential full-time caregivers”. Using this analysis, we estimated the hypothetical health care expenditure and HbA1c and showed that male patients have higher expenditure and lower HbA1c when their caregiver is a potential full-time caregiver, whereas younger female patients have higher health care expenditure and lower HbA1c when their caregiver is employed. This finding is not meant to serve as criticism of health care policy in this area; rather, the aim is to contribute to economic policy in Japan for T1DM patients 20 years and older.

1. Introduction

Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by an absolute insulin deficiency resulting from the progressive immune-mediated destruction of pancreatic islet β cells. T1DM depends on “luck”, which occurs through an autoimmune mechanism in young people until puberty. Management of T1DM requires many lifelong daily tasks, e.g., glucose monitoring, adherence to insulin regimen, and meal planning that the child and/or family must perform to maintain a healthy metabolism and glycaemic control [1]. The main treatment methods are multiple daily insulin injections (MDI), continuous subcutaneous insulin infusion (CSII), and sensor-augmented pump (SAP). Except with CSII and SAP, automatic glucose measurement and self-monitoring of blood glucose must take place before insulin injections. Particularly when the patient is a child, parents will function as care coordinators, alongside health professionals and system supporters in addition to their regular parenting duties.
Many studies report a strong socio-economic gradient in health, regardless of the population studied and the method of measurement [2,3,4,5,6,7,8,9,10]. Regarding T1DM, besides factors relating to poor adherence to diabetes treatment, socio-economic status (SES) and other family demographic factors such as maternal education and knowledge, rural residence, and distance from the clinic influence HbA1c (the standard measure used for assessing long-term glycaemic control) [11,12,13,14,15,16,17,18,19,20,21] are of the opposite argument, in that the causality runs from health to SES, as in recent empirical studies by [22,23]. The diagnosis of chronic disease in a child affects not only the patient but also the child’s family [24,25]. This may lead to a deterioration in the family’s employment situation and a reduction in income, for example, if the patient is unable to work or attend school or if the patient’s parents must leave their jobs to look after the patient. Previous research has clarified that T1DM in childhood has a negative effect on labour market outcomes later in life, which means the causality instead runs from health to SES [26].
In Japan, the “Child Chronic Specified Disease Treatment Project” based on the Child Welfare Law covers medical expenses for T1DM until the child turns 20 years old. Afterwards, patients bear the costs of all daily treatment. Any change in the treatment plan may also have a negative impact on the patient’s health and socio-economic status. It is difficult for paediatric patients with T1DM to inject insulin independently, and they require parental or guardian care. The literature has found that parental and spousal recommendations are important in the demand for better medical equipment, not only for paediatric patients but also for adult patients [27]. Previous studies have identified the causal impact of SES on health levels and health levels on SES. However, they have not investigated the impact of the SES of caregivers. In studies of inequality, it is common to consider SES background at 15 years of age, and this paper employs this approach to studying T1DM. To address this, this study focuses on the impact of SES on health status and vice versa, with particular attention to differences in the SES of caregivers of patients with T1DM in Japan. We also estimate the hypothetical value of the impact of either health care funding or caregiver presence on blood glucose levels as measured by HbA1c. We use these results to suggest directions for health care funding for patients with chronic disease in Japan.
Focusing on Japan, the number of children requiring daily medical care (usually called “medical care children” in Japan) is increasing each year, with 18,272 cases in 2016 [28], especially for parents, who are the primary caregivers of children in medical care, and the load on mothers is particularly high. Despite this, in Japan, most studies have focused on the employment of patients themselves, and there are fewer studies concerning the employment of the caregivers of paediatric patients than in other countries. There is a lack of basic national data on the employment status of families with children in medical care. There are no concrete measures to support parents’ employment.
From this point of view, one representative study is [29], in which a survey was conducted regarding 639 mothers of adults with intellectual disabilities. It reported that the employment rate of women in their 50s was 39.8%, compared with 61.5% for married women in general. Another study [30] also revealed that the employment rate of women with “medical care children” was only 42.7%. Among working mothers, 53.1% were engaged in a professional or technical job [30]. This reflects the higher costs to care for medical care children directly or indirectly, with an alternative strategy for mothers of paediatric patients allocating money earned through working in a high-income occupation.
Figure 1 illustrates the flowchart of causality running from SES to health level and health level to SES. Regarding Figure 1, does the inactivity of the patient and their family’s work lead to a lack of access to high-quality medical treatment? or does it lead to maintain health condition by concentrating on care? To solve this puzzle, we need to focus on the labour status of the patient and their family.
In this paper, we attempt to evaluate the following hypothesis regarding mothers or spouses (both wife and husband) becoming full-time homemakers or caretakers, i.e., “potential full-time caregiver”. To respond to this question, we obtain counterfactual out-of-pocket medical expenditure and HbA1c, especially shedding light on labour status of the patient’s caregiver after using regression analysis to clarify the socio-economic factors of determining out-of-pocket medical expenditure and HbA1c.
The rest of the paper is organized as follows. Section 2 explains the materials and methods. Section 3 provides the regression results for out-of-pocket medical expenses and HbA1c and counterfactual outcomes for the caregiver. Using these results, we then estimate the counterfactual HbA1c, given health care funding and caregiver availability. Section 4 discusses health care subsidies and economic policies for T1DM in Japan, and Section 5 is the conclusion.

2. Materials and Methods

2.1. Materials

In this section, we explain about the materials, e.g., the design, setting and population under the study.
There are also a few surveys [31,32,33] conducted on the socio-economic aspects of T1DM patients. However, it is not possible to study the socio-economic background of the patients and their families and the effect of the treatment because of the following reasons.
Ref. [34] provides descriptive statistics on the status of patients who received the “Child Chronic Specified Disease Treatment Project” as of 2010; however, it does not include patients developing the disease over 20 years old. Ref. [35] also provides the study based on the survey for not only under-20-years-old patients but also for over-20-years old patients; however, it does not contain the feature of disease, e.g., onset age, seriousness, and socio-economic background of patients and their parents, since the survey is conducted through the patient’s physician.
We administered an original questionnaire survey to T1DM patients and their families in Japan over the Internet during the period from 4 November to 2 December 2016, by collaborating with the largest association of T1DM patients in Japan, the Japan IDDM Network, and a network management company, NTT Com Online Marketing Solutions Corporation (hereinafter “NTT Com”) to ensure sufficient sample size. We used information on the monitors registered with NTT Com. In total, 947 respondents participated in the survey, but only 410 responses were valid, as we restricted the sample to those using medical devices such as MDI, CSII, and SAP. The information gathered comprises demographic (age, sex, and place of residence), socio-economic (marital status, employment status, and income level), and health and health economic (age at onset of T1DM, diabetic complications, treatment choice, out-of-pocket medical expenses, frequency of hospital/clinic visits, and government financial aid) variables. While suitable epidemiological surveys exist as is mentioned above, this is the first detailed socio-economic survey of T1DM patients in Japan, making the survey findings in themselves a significant contribution to the literature.
As mentioned, in Japan, the cost of medical care up to the age of 20 declines because of the “Grant-in-Aid Program for Chronic Diseases in Childhood”. This system reduces out-of-pocket expenses for children with target diseases, including T1DM. Thus, patients younger than 20 are eligible for aid through which the co-payment rate reduces to 20%, subject to an upper bound on the monthly out-of-pocket payments. This varies according to parental household income to a maximum of JPY 10,000 (USD 91, assuming an exchange rate of USD1 = JPY 110). In summary, an eligible patient pays the lower amount of the 20% co-payment and the out-of-pocket cost limit. This financial aid for the patient ends at the age of 20. As no similar government support exists for adult T1DM patients, they must pay the usual 30% co-payment. Table 1 summarizes the typical out-of-pocket expenses for a T1DM patient (based on age). The “Special Child Rearing Allowance” provides governmental income support for parents who look after their disabled children at home. A T1DM patient younger than 20 is eligible for second-degree disabilities. As of 2018, parents receive a monthly allowance of JPY 34,430 (USD 313). Given the costs involved and the low level of government assistance, a diagnosis of T1DM is then increasingly responsible for catastrophic expenditures that push patients and their families into a medical poverty trap.
The out-of-pocket medical expenses include the medical costs for treating T1DM and its complications. The independent variables include household income, onset timing, the frequency of outpatient service use, the number of complications, a time discount rate, a female dummy, a care dummy by age range, and government aid. Table 1 provides the details and descriptive statistics for the independent variables.
We briefly describe the epidemiological findings arising from the descriptive statistics, which is shown in Table 1. Table 1 contains 2 brackets; one is for continuous variables and the other is categorical variables.
The upper bracket of Table 1 contains the descriptive statistics for continuous variables. The explanation of each continuous variable is below. First, out-of-pocket medical expenses are the amount of out-of-pocket expenses for IDDM treatment and complications during 2015. The amount was paid at the medical institution, even if patients received a refund due to “High-cost Medical Expense Benefit”. This “High-cost Medical Expense Benefit” can be claimed if the cost-bearing limit of medical expenses exceeds the specified amount for the month. The total amount (30% of medical costs) is paid first, and a refund is later received. In the questionnaire, we asked, “Please provide the amount of your out-of-pocket expenses for IDDM treatment and complications over the last year. (*Please enter the amount you paid at the medical institution, even if you received a refund due to high-cost medical care expenses, etc.)”. Second, household income is the amount of household income in 2015. Lastly, HbA1c is the latest HbA1c value (NGSP value), and we asked, “Please provide us with the most recent HbA1c value (NGSP value) of patient”.
The lower bracket of Table 1, however, contains the descriptive statistics for categorical variables.
In the questionnaire, we asked whether respondents have the following complications: diabetic retinopathy, diabetic nephropathy, neuropathy, gangrene, coronary artery disease, cerebrovascular disease, other. As for complications, most patients do not experience any complications.
Time discount was obtained from the question “How much would you be happy to receive as a minimum after 13 months instead of JPY 10,000 (USD 91, assuming an exchange rate of USD 1 = JPY 110) after one month?” shows the discount placed on returns receivable or costs payable in the future. The use of a high discount rate implies that people place less weight on the future and that they are impatient. Most of the time discount rate is under 10%, which means that they place high weight on the future.
As for the varying timings of onset, around 48.7% of patients experience the onset of T1DM after age 30, which is consistent with [33]. Those who had an onset over the age of 20 were unable to be captured by previous surveys in Japan, e.g., [34,35], which aimed to track juvenile onset and “Grant-in-Aid Program for Chronic Diseases in Childhood” users.
The most frequent use of outpatient services is once per month.
Next, we shift to the explanation of the variable of caregiver of patients. As for juvenile patients, it has been pointed out that 97.5% of children with disabilities at home are primarily cared for by their mothers, and that children with medical care place a heavy load on mothers [36,37]. It is clarified that patients with a spouse demand newly developed medical equipment in [27]; thus, we focus on patients’ mothers and spouses as caregivers, which is categorized as “care dummy” in this article.
We specify the care dummy by age range. If the patient’s mother or spouse, for both wife and husband, is a full-time homemaker or not working, the caregiver dummy takes a value of one, otherwise zero. Hereinafter, we define this caregiver as a “potential full-time caregiver”.
In the field of labour economics, there is a socio-economic bias when engagement of a patient’s mother or wife in paid work is related to their own and husband’s economic level, a tendency recognized as “Douglas–Arisawa’s second law”. The rule of thumb is that the higher the head of household’s income, the less likely the spouse has a job. However, theoretically, we can dismiss such a bias because of the random onset of T1DM. As can be seen from the descriptive statistics, the labour status of the mother or spouse of a patient under 20 years old indicates low labour force participation. For single patients under 20, 63.46% of mothers work. This result is consistent with previous studies, such as in [30].
Lastly, we also focus on those who receive governmental aid. This “government aid dummy” takes a value of one if the patient under 20 years old receives at least one of the “Grant-in-Aid Program for Chronic Diseases in Childhood” or “Special Child Rearing Allowance”; otherwise, it is zero. For example, for adult recipients who have received some government aid in the past, the dummy variable has a value of zero.

2.2. Methods

Generally, experiments are difficult in the field of social sciences. However, in recent years, methods have been developed to predict social phenomena by assuming hypothetical values. The most popular methodology is a randomized controlled trial, known as RCT, which randomly divides a target group (e.g., patients with a particular disease) into several groups (e.g., treatment groups and control groups) and measures and clarifies the impact/effect of the experimental intervention.
In this paper, to see how the caregiver’s employment status determines out-of-pocket medical expenditure and HbA1c, we have to estimate how hypothetical marginal effects of becoming a “potential full-time caregiver” increase out-of-pocket medical expenditure or worsen HbA1c.
Upon the discussion above, caregivers should be randomized into the two groups by their employment status (e.g., “potential full-time caregiver” vs. no “potential full-time caregiver”) to treat confounding effects; however, it is unavoidable given the study design since interventions for working and labour status hardly happen. To curb this problem as much as possible, this paper employs the margin effect analysis which assumes hypothetical values.
Based on Equation (1), we run the regression for out-of-pocket medical expenditure and HbA1c.
y i is out-of-pocket medical expenditure and HbA1c, and x i contains household income, onset timing, frequency of outpatient visits and number of complications, time discount rate, care dummy by age range and government aid dummy. The subscript i indicates an individual, and ε is the error term.
y i = α + β i x i + ε
We provide the results for a divided sample (male and female). First, we estimate out-of-pocket medical expenses, and then HbA1c.
After conducting the regression, we estimate the counterfactual out-of-pocket medical expenses and HbA1c based on the caregiver’s labour status.
To obtain counterfactual out-of-pocket medical expenses and HbA1c, we use marginal effect as is described in Equation (2).
y i x i = β i
Especially, we try to obtain predicted value applying the effect of caregiver’s labour status when government aid exists or not and marginal effects of the independent variable x i   constituting the interaction. Then, we estimate the four predicted values.
To answer the research question, we estimate the marginal effect on:
  • The out-of-pocket medical expenditure of care dummy by age;
  • HbA1c of care dummy by age range;
  • HbA1c of care dummy and government aid by age range.
The first values show which caregiver’s labour status affects the out-of-pocket medical expenditure. The second values display which caregiver’s labour status affects HbA1c, and the last values show which caregiver’s labour status affects HbA1c with/without governmental aid.
For the actual analysis, this paper used the margins command in Stata following [38].
As is noted above, even when using the margins command to calculate hypothetical values, there are confounding effects present.

3. Results

This section explains the results of the regression for out-of-pocket medical expenses and HbA1c and then those for the marginal effects of the care dummy. After these estimations, we obtain the marginal effect on HbA1c of care dummy by age range and government aid to see how caregiver’s labour status affect HbA1c under the exist/absence of government aid.
Table 2 and Table 3 provide the results relating to out-of-pocket medical expenses, with those for HbA1c in Table 4, Table 5 and Table 6. Table 7 shows the marginal effect on HbA1c of care dummy by age range and government aid.
To start, we discuss the regression estimates and marginal effects for out-of-pocket medical expenses, with Table 2 providing these by subgroup. Model 1 shows the results for the whole sample, with Models 2 and 3 for the male and female patient subgroups, respectively.
Table 2 shows the regression results of out-of-pocket medical expenses.
Model 1 presents significant results focusing on the whole sample, household income, the frequency of outpatient use, especially once or few times per week/month, the time discount rate, the female dummy, 40–49 years old and working caregiver, and government aid. This means that higher-income households incur higher out-of-pocket medical expenses. By contrast, there are significant negative effects for the government aid dummy. A lower frequency of outpatient visits reduces out-of-pocket medical expenses, while a high time discount rate indicating that patients tend to be impatient is also positively related to out-of-pocket expenses. The caregiver dummy by age range, 40–49 years old, and working caregiver exhibit negative estimates.
Models 2 and 3 show similar findings. However, what is interesting is the value for the care dummy by age range. Among results for male patients, a patient who is 10–19 years old and has a “potential full-time caregiver” has a significant positive value. By contrast, for female patients, some categories of the care dummy by age range exhibit significant negative estimates. Table 3 details the marginal effects of the care dummy by age range.
Table 2 shows the predicted value on the out-of-pocket medical expenditure of care dummy by age.
In terms of counterfactual medical expenses, that of “potential full-time caregiver” suggests higher expenditure for both 20–29-year-old male patients and 40–49-year-old female patients whose spouse or mother is at least a full-time homemaker. Outside these two categories, the counterfactual out-of-pocket medical expenditure when the caregiver works displays a higher value. In the analysis above, the caregiver variable exerts a significant effect for female patients, and attention is given to this in the following discussion.
Middle-aged patients with a “potential full-time caregiver” incur higher out-of-pocket medical expenditures. We suggest two reasons: direct and indirect. A “potential full-time caregiver” may have the capacity to care regarding a patient’s health condition and frequency of outpatient visits. Conversely, middle-aged patients are eager to maintain their health condition to support their family. Nonetheless, what matters is not out-of-pocket medical expenditure, but rather the level of the patient’s health.
Next, we refer to the regression estimates and marginal effects where HbA1c serves as the dependent variable. Table 4 and Table 5 provide the results for estimated HbA1c for male and female patients using Models 4 and 5 and Models 6 and 7, respectively.
As shown in Table 4, for male patients, one complication, the time discount rate, and the government aid dummy show significant estimates. To focus on the care variable, we add Model 5. In Model 5, the care dummy displays significant negative results, which indicates that a full-time homemaker/mother leads to an improved HbA1c level.
Table 5, which provides the estimation results for female patients, the onset timing especially for 10–19 years and 30–49 years, the frequency of outpatient visits, two or more complications, and 20–39-year-old patients with a “potential full-time caregiver”, exhibits significant results. Focusing on the onset timing, we can confirm that adolescent onset leads to rising HbA1c, especially for female patients.
The results in Table 6 provide two interesting points. One is that with paediatric patients, having a “potential full-time caregiver” leads to a lower HbA1c, which we can clarify by comparing Cases 1 and 2 and Cases 3 and 4. Another is that for all other ages except females aged 40–49 years old, “potential full-time caregiver” is related to a higher HbA1c level.
In the youngest age group, homemakers have a better HbA1c, but in the adult group, HbA1c is worse. We suggest that this is because of governmental subsidies for paediatric health care. HbA1c may be lower in younger people with less financial burden and who can provide better care. This may be because the financial burden is lower in the younger age group because of subsidized health care, and the presence of homemakers allows them to take better care of their children, resulting in a lower HbA1c. Finally, in this section, we look at the effect of caregiver employment status and health care subsidies.
Table 7 shows the predicted value aiming at how caregiver’s labour status affects HbA1c by the case of whether the governmental aids exist or do not exist.
The results in Table 7 provide three main findings. First, for patients under 40 years old and female, a “potential full-time caregiver” is superior to government aid in lowering the level of HbA1c. Second, except for this age group, having a working caregiver leads to a better HbA1c than having a “potential full-time caregiver”. Finally, for all ages, there are significant differences for male and female patients. For male patients, the presence of a caregiver rather than government aid is more important in maintaining HbA1c. For female patients, a working spouse or mother is important for maintaining the HbA1c level. However, the difference is smaller than for male patients.

4. Discussion

The purpose of the analysis conducted in this study was to gain a better understanding of the correlations between the labour status of caregivers of diabetic patients and out-of-pocket medical expenditure, HbA1c and governmental aid.
Studies on the issues of labour status associated with providing care to patients with diabetes and factors influencing out-of-pocket medical expenditure and HbA1c considering governmental aid have not been conducted in Japan before.
In the previous section, we conducted a regression analysis of health care expenditures and HbA1c by considering not only the patient but also the SES of the caregivers, and based on the results, estimated counterfactual health care expenditures and HbA1c given the employment status of caregivers. We also estimated the counterfactual out-of-pocket medical expenditure and HbA1c based on caregiver working status.
We found that the impact of caregivers on counterfactual out-of-pocket medical expenditure was negative for younger age groups when the patient was female, i.e., out-of-pocket medical expenditure was lower. Based on the analysed counterfactual out-of-pocket medical expenditure, middle-aged patients with a full-time house-caregiver incur higher out-of-pocket medical expenditures. We explain this finding both directly and indirectly. Directly, a full-time house-caregiver may have more allowance to care about a patient’s health condition and the frequency of outpatients. Indirectly, middle-aged patients are eager to maintain their health condition to support the patient’s family. In terms of HbA1c, the full-time caregiver dummy is significant for all age groups for men and 20–39-year-old women. Based on these results, we estimated HbA1c and found that for women under 40 years old, having a “potential full-time caregiver” rather than government support was associated with lower HbA1c levels. However, this result is not always valid in the case of long-term data analysis, since it is referred that families that experience reduced financial resources because of lost income from either a cut in work hours or having to stop work were perceived to be a more significant financial burden, and often responded that they needed additional income to cover medical expenditures [39].
The expenditure amount may be relatively small compared to other household expenses; families with children who need special health care may be financially stretched because of many years of persistent costly care resulting in lower expenditures causing the perceptions of problems [40].
It is also referred that meeting the fiscal demands of health care expenditures with decreased financial resources may result in families selling assets, taking out loans or mortgages, using savings, or seeking additional employment [41]. Re-establishing financial well-being may be hindered by decreased employability and loss of career advancement and mobility caused by being out of the workplace for any extended period to care for the child [42]. Taken together with the regression analysis results, this effect is likely to be more vital for those aged between 20 and 40. In combination with the significant consequences for the regression analysis (Model 5) for all age groups of men, the presence of an unemployed person at home contributes to lowering HbA1c and maintaining health. Finally, we estimated a hypothetical HbA1c based on the caregiver’s employment status and the availability of health care subsidies. The results show that for men, the presence of a caregiver is more critical for maintaining HbA1c than government assistance, with a difference of about two. For women under 40 years of age, the presence of a working caregiver rather than government assistance can lead to lower HbA1c levels. In other words, the presence of a caregiver who can afford to always care for a patient is linked to the level of health for men and women 40 and older, whereas the presence of a caregiver working and supporting the patient financially is linked to the level of health for women under 40. The reduction in HbA1c levels brought about by the presence of a caregiver is also greater among younger age groups. As discussed, Japan’s only policy for people with T1DM is to subsidize medical costs up to the age of 20. It is shown that removing this subsidy has led to distorted demand for medical equipment [27]. Nonetheless, they have also shown that family recommendations strongly affect the demand for medical equipment. This means that the presence of caregivers has a significant impact on the level of health of people with T1DM.

5. Conclusions

This study focused on the impact of SES on health status and vice versa, with particular attention to differences in the SES of caregivers of patients with T1DM in Japan. Using an original survey conducted in 2016 targeted at Japanese T1DM patients, we studied the following three points:
  • We ran the regression on out-of-pocket medical expenditure and HbA1c based on the patient’s and caregiver’s socio-economic factors, especially the caregiver’s labour status.
  • Based on the above results, we estimated counterfactual out-of-pocket medical expenditure and HbA1c.
  • We also estimated a hypothetical value of the impact of either health care funding or caregiver presence on blood glucose levels.
When we looked at differences in caregiver employment status, we found that the effects varied by sex and patient age. As is noted in Section 2, to obtain the true effect of caregiver’s employment status, a randomized control trial should be applied; however, it is unavoidable given the study design, and we employed marginal effect analysis for this attempt, which means there are surely confounding effects present which should be taken into consideration. The overall finding is that counterfactual HbA1c is more influenced by caregiver employment status than by government funding. For women under 40 years old, HbA1c was lower when the caregiver was employed. For the rest of the population, men and women 40 and older having an unemployed caregiver resulted in a lower HbA1c. As discussed, this conclusion is not for the purpose of denying the benefit of government aid such as the “Grant-in-Aid Program for Chronic Diseases in Childhood” and “Special Child Rearing Allowance”. These governmental aids are available only to paediatric patients, and they have time restrictions. In future research, we will assess how continuous economic policy relating to T1DM patients would be appropriate.
The conclusions of this paper do not negate the need for health care funding. This is because medical devices such as SAPs and CSIIs, which lower HbA1c, have either not yet penetrated the Japanese health care system or are not used because they interfere with daily life and require blood glucose control by oneself or family members. Therefore, if patients, their families, and doctors are informed about these medical devices, and if the quality of medical devices further improves, it is expected to be more effective than the presence of caregivers. Further, while there is a need for additional analysis, it seems that there is also a need for economic policies such as employment and wages for people with T1DM and their families, rather than time-limited health care subsidies.

Funding

This research was supported by the Japanese IDDM network and the Japan Society for the Promotion of Science through KAKENHI grant no. 18K02176. The funders were not involved in the study design, data collection, data analysis, interpretation, writing, or decision to submit this journal article for publication.

Institutional Review Board Statement

The study was conducted according to the guidelines of Kyoto University and approved by the Research Ethics Committee of Graduate School of Pharmaceutical Science, Kyoto University. (approval date: 14 November 2016).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy reasons.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dantzer, C.; Swendsen, J.; Maurice-Tison, S.; Salamon, R. Anxiety and depression in juvenile diabetes: A critical review. Clin. Psychol. Rev. 2003, 23, 787–800. [Google Scholar] [CrossRef]
  2. Ettner, S.L. New evidence on the relationship between income and health. J. Health Econ. 1996, 15, 67–85. [Google Scholar] [CrossRef]
  3. Bloom, D.E.; Canning, D. The health and wealth of nations. Science 2000, 287, 1207–1209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Smith, J.P. Healthy bodies and thick wallets: The dual relation between health and economic status. J. Econ. Perspect. 1999, 13, 145–166. [Google Scholar] [CrossRef] [Green Version]
  5. Benzeval, M.; Judge, K. Income and health: The time dimension. Soc. Sci. Med. 2001, 52, 1371–1390. [Google Scholar] [CrossRef]
  6. Gerdtham, U.-G.; Johannesson, M. Income-related inequality in life-years and quality-adjusted life-years. J. Health Econ. 2000, 19, 1007–1026. [Google Scholar] [CrossRef] [Green Version]
  7. Gerdtham, U.-G.; Johannesson, M. Absolute income, relative income, income inequality, and mortality. J. Hum. Resour. 2004, 39, 228–247. [Google Scholar] [CrossRef]
  8. Baum, C.L., II.; Ruhm, C.J. Age, socioeconomic status and obesity growth. J. Health Econ. 2009, 28, 635–648. [Google Scholar] [CrossRef] [Green Version]
  9. Deaton, A. Health, inequality, and economic development. J. Econ. Lit. 2003, 41, 113–158. [Google Scholar] [CrossRef]
  10. Nordin, M.; Dackehag, M.; Gerdtham, U.-G. Socioeconomic inequalities in drug utilization for Sweden: Evidence from linked survey and register data. Soc. Sci. Med. 2013, 77, 106–117. [Google Scholar] [CrossRef]
  11. Davies, M.J.; Gagliardino, J.J.; Gray, L.J.; Khunti, K.; Mohan, V.; Hughes, R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: A systematic review. Diabet. Med. 2013, 30, 512–524. [Google Scholar] [CrossRef]
  12. Deladoëy, J.; Henderson, M.; Geoffroy, L. Linear association between household income and metabolic control in children with insulin-dependent diabetes mellitus despite free access to health care. J. Clin. Endocrinol. Metab. 2013, 98, E882–E885. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Hatherly, K.; Smith, L.; Overland, J.; Johnston, C.; Brown-Singh, L.; Waller, D.; Taylor, S. Glycemic control and type 1 diabetes: The differential impact of model of care and income. Pediatric Diabetes 2011, 12, 115–119. [Google Scholar] [CrossRef] [PubMed]
  14. Stumetz, K.S.; Joyce, P.; Mitrovich, C.; Early, K.B. Quality of care in rural youth with type 1 diabetes: A cross-sectional pilot assessment. BMJ Open Diabetes Res. Care 2016, 4, e000300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Al-Odayani, A.N.; Alsharqi, O.Z.; Ahmad, A.M.; Khalaf Ahmad, A.M.; Al-Borie, H.M.; Qattan, A.M. Children’s glycemic control: Mother’s knowledge and socioeconomic status. Glob. J. Health Sci. 2013, 5, 214–226. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Tahirovic, H.; Toromanovic, A. Glycemic control in diabetic children: Role of mother’s knowledge and socioeconomic status. Eur. J. Pediatrics 2010, 169, 961–964. [Google Scholar] [CrossRef] [PubMed]
  17. Galler, A.; Lindau, M.; Ernert, A.; Thalemann, R.; Raile, K. Associations between media consumption habits, physical activity, socioeconomic status, and glycemic control in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 2011, 34, 2356–2359. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Gomes, M.B.; De Mattos Matheus, A.S.; Calliari, L.E.; Luescher, J.L.; Della Manna, T.; Savoldelli, R.D.; Cobas, R.A.; Coelho, W.S.; Tschiedel, B.; Ramos, A.J.; et al. Economic status and clinical care in young type 1 diabetes patients: A nationwide multicenter study in Brazil. Acta Diabetol. 2013, 50, 743–752. [Google Scholar] [CrossRef]
  19. Caccavale, L.J.; Weaver, P.; Chen, R.; Streisand, R.; Holmes, C.S. Family density and SES related to diabetes management and glycemic control in adolescents with type 1 diabetes. J. Pediatric Psychol. 2015, 40, 500–508. [Google Scholar] [CrossRef] [Green Version]
  20. Strauss, K.; MacLean, C.; Troy, A.; Littenberg, B. Driving distance as a barrier to glycemic control in diabetes. J. Gen. Intern. Med. 2006, 21, 378–380. [Google Scholar] [CrossRef] [Green Version]
  21. Üstün, T.B.; Chatterji, S.; Kostanjsek, N.; Rehm, J.; Kennedy, C.; Epping-Jordan, J.; Saxena, S.; Korff, M.V.; Pull, C. Developing the World Health Organization disability assessment schedule 2.0. Bull. World Health Organ. 2010, 88, 815–823. [Google Scholar] [CrossRef] [PubMed]
  22. Lundborg, P.; Nilsson, A.; Rooth, D.-O. Adolescent health and adult labor market outcomes. J. Health Econ. 2014, 37, 25–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Currie, C.J.; Peters, J.R.; Tynan, A.; Evans, M.; Heine, R.J.; Bracco, O.L.; Zagar, T.; Poole, C.D. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. Lancet 2010, 375, 481–489. [Google Scholar] [CrossRef]
  24. Knafl, K.A.; Darney, B.G.; Gallo, A.M.; Angst, D.B. Parental perceptions of the outcome and meaning of normalization. Res. Nurs. Health 2010, 33, 87–98. [Google Scholar] [CrossRef] [Green Version]
  25. Waite-Jones, J.M.; Madill, A. Amplified ambivalence: Having a sibling with juvenile idiopathic arthritis. Psychol. Health 2008, 23, 477–492. [Google Scholar] [CrossRef] [Green Version]
  26. Persson, S.; Gerdtham, U.G.; Carlsson, K.S.; Swedish Childhood Diabetes Study Group. Labor market consequences of childhood onset type 1 diabetes. Econ. Hum. Biol. 2016, 23, 180–192. [Google Scholar] [CrossRef]
  27. Sakoda, S.; Tamura, M.; Wakutsu, N. What Discourages Adults’ Use of Insulin-Infusion Pumps in Japan, Habit or Financial Aid? in press.
  28. Tamura, M. Research on the Actual Conditions of Children in Medical Care and the Promotion of Cooperation between Medical Care, Welfare, Health and Education. 2017. Available online: https://research-er.jp/projects/view/998532/1026420 (accessed on 31 January 2022).
  29. Tanaka, M. Poverty of Families with Mentally Retarded Persons and Its Structural Understanding (Special Issue on Poverty of Children with Disabilities). J. Probl. Pers. Disabil. 2010, 37, 261–272. (In Japanese) [Google Scholar]
  30. Araki, S.; Nakamura, K.; Kashiwabara, Y.; Eguchi, H.; Shimono, M. A Field Survey of Working Conditions of Parents with Children Requiring Medical Care. J. UOEH 2019, 41, 171–178. (In Japanese) [Google Scholar] [CrossRef] [Green Version]
  31. Carnevale, F.A.; Alexander, E.; Davis, M.; Rennick, J.; Troini, R. Daily living with distress and enrichment: The moral experience of families with ventilator-assisted children at home. Pediatrics 2006, 117, e48–e60. [Google Scholar] [CrossRef] [Green Version]
  32. Loucks, C.A. The Experiences of Families Raising Children with Type 1 Diabetes Mellitus: A Qualitative Investigation. 2011. Available online: http://hdl.lib.byu.edu/1877/etd4679 (accessed on 31 January 2022).
  33. Thomas, N.J.; Jones, S.E.; Weedon, M.N.; Shields, B.M.; Oram, R.A.; Hattersley, A.T. Frequency and phenotype of type 1 diabetes in the first six decades of life: A cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018, 6, 122–129. [Google Scholar] [CrossRef] [Green Version]
  34. Ojima, T. Study on the Actual Conditions and Needs of Carry-Over Patients with Chronic Specific Diseases of Childhood, Ministry of Health, Labour and Welfare Science Research Grant Research. 2011. Available online: http://plaza.umin.ac.jp/~carry/work/bassui.pdf (accessed on 31 January 2022).
  35. Tajima, N. Study on the Epidemiology and Living Conditions of Type 1 Diabetes: A Comprehensive Research Report for 2014–2015; Ministry of Health, Labour and Welfare of Japan: Tokyo, Japan, 2015. (In Japanese)
  36. Ozawa, H.; Kimitsuya, T.; Funahashi, M.; Miyaji, S.; Kurata, K.; Tanuma, N.; Sasaki, S. A survey on the actual conditions of children and persons with very serious illness in the Tama district of Tokyo. J. Jpn. Soc. Pediatrics 2010, 114, 1892–1895. [Google Scholar]
  37. National Center for Child Health and Development. Final Report of the 2014 Project for the Coordination of Home Medical Care for Children; National Center for Child Health and Development: Tokyo, Japan, 2015. (In Japanese) [Google Scholar]
  38. Williams, R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012, 12, 308–331. [Google Scholar] [CrossRef] [Green Version]
  39. Lindley, L.C.; Mark, B.A. Children with Special Health Care Needs: Impact of Health Care Expenditures on Family Financial Burden. J. Child Fam. Stud. 2010, 19, 79–89. [Google Scholar] [CrossRef] [Green Version]
  40. Himmelstein, D.U.; Warren, E.; Thorne, D.; Woolhandler, S. Illness and injury as contributors to bankruptcy. Health Aff. Suppl. Web Exclus. 2005, 7, W65-63–W65-73. [Google Scholar] [CrossRef] [Green Version]
  41. Emmanuel, E.; Fairclough, D.; Slutsman, J.; Emmanuel, L. Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers. Ann. Intern. Med. 2000, 132, 451–459. [Google Scholar] [CrossRef]
  42. Miedema, M.; Easley, J.; Fortin, P.; Hamilton, R.; Mathews, M. The economic impact on families when a child is diagnosed with cancer. Curr. Oncol. 2008, 15, 173–178. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Flow chart of mutual relationship of SES and health level.
Figure 1. Flow chart of mutual relationship of SES and health level.
Ijerph 19 01629 g001
Table 1. Descriptive statistics for continuous variables.
Table 1. Descriptive statistics for continuous variables.
MaleFemale
VariableMeanStd. Dev.MinMaxMeanStd. Dev.MinMax
Out-of-pocket medical
Expenses
124,793
(JPY)
165,4680
(JPY)
1,500,000
(JPY)
158,653
(JPY)
137,7580
(JPY)
800,000
(JPY)
Household income5,804,537
(JPY)
3,892,6840
(JPY)
25,000,000
(JPY)
4,723,366
(JPY)
6,063,3470
(JPY)
65,000,000
(JPY)
HbA1c7.341.294107.261.09410
MaleFemale
ObservationsProportion (%)ObservationsProportion (%)
Complication
No complication14872.2017183.41
One complication4220.492311.22
Two or more complication157.32115.37
Time discount rate
−5–0%4019.513517.07
2–6%4722.932713.17
10%3919.025828.29
20%3014.633416.59
40%4923.905124.88
The frequency of outpatient visit
Once or few times per week2612.68136.34
Once per month14570.7315977.56
Once or few times per year3416.593316.10
Onset timing
0–9 years old2713.174320.98
10–19 years old2813.663718.05
20–29 years old3416.594120.00
30–39 years old5426.343517.07
40–49 years old3718.052512.20
Over 50 years old2512.202411.71
Care dummy by age range
10–19 years old
working caregiver1765.381864.29
“potential full-time caregiver”934.621035.71
20–39 years old
working caregiver3683.726993.24
“potential full-time caregiver”716.2856.76
40–49 years old
working caregiver4067.85292.86
“potential full-time caregiver”1932.247.14
50 years and older
working caregiver4761.043574.47
“potential full-time caregiver”3038.961225.53
Government aid dummy
Not receiving18188.2917987.32
Receiving2411.712612.68
Subtotal205 205
Table 2. Estimated out-of-pocket medical expenses.
Table 2. Estimated out-of-pocket medical expenses.
Model 1Model 2Model 3
MaleFemale
VariablesMedical ExpenditureMedical ExpenditureMedical Expenditure
Household income0.00561 ***0.002730.00706 ***
(0.00149)(0.00334)(0.00148)
Onset timing
0–9 years old3701–41,4211216
(28,874)(52,926)(34,917)
10–19 years old34,83271,869 *–12,601
(26,171)(43,319)(32,339)
20–29 years old23,950–920.524,830
(23,789)(38,377)(29,457)
40–49 years old–260123,819–67,279 *
(25,878)(37,475)(37,390)
50 years and older–27,64921,493–124,258 **
(30,985)(45,317)(47,761)
Frequency of outpatient visits
Once or a few times per week–46,932*–63,130 *–41,855
(25,387)(36,250)(36,989)
Once or a few times per year–31,422–52,121–29,499
(21,663)(36,812)(25,981)
Number of complications
One complication–7156–127714,039
(22,245)(32,937)(31,671)
Two or more complications–219830,028–54,915
(31,526)(48,585)(43,088)
Time discount rate
–5–0%25,65631,77810,687
(22,883)(36,437)(27,938)
2–6%–17,564–1836–43,965
(23,688)(36,392)(29,975)
10%4667–669336,125
(21,372)(36,253)(28,111)
20%52,941 **73,016 *–13,180
(24,145)(39,516)(25,502)
Female dummy28,553 *
(15,645)
Care dummy by age range(Reference: 50 years and older * working caregiver)
10–19 years old*working caregiver–21,074179,956–247,902 **
(81,679)(127,128)(102,972)
10–19 years old and “potential full-time caregiver”–5428229,617 *–256,733 **
(82,134)(128,330)(103,358)
20–39 years old and working caregiver–795951,982–78,389 **
(27,496)(44,061)(38,313)
20–39 years old and “potential full-time caregiver”–17,017–22,025–16,600
(47,974)(70,294)(65,612)
40–49 years old and working caregiver–46,630 *–25,038–90,744 ***
(25,310)(38,186)(34,768)
40–49 years old and “potential full-time caregiver”–52,497–27,051–101,597
(36,070)(46,253)(72,257)
50 years and older and working caregiver000
(0)(0)(0)
50 years and older and “potential full-time caregiver”–39,671–4437–47,351
(28,323)(40,125)(45,574)
Government aid dummy–132,319 *–276,758 **25,930
(76,657)(119,933)(93,531)
Constant129,261 ***104,400 **240,710 ***
(28,614)(42,619)(42,346)
Observations410205205
R-squared0.1540.1590.283
Prob > F0.00000.05880.0000
Standard errors in parentheses
*** p < 0.01, ** p < 0.05, * p < 0.1.
Table 3. Marginal effect on the out-of-pocket medical expenditure of care dummy by age.
Table 3. Marginal effect on the out-of-pocket medical expenditure of care dummy by age.
MaleFemale
Marginal ValueMarginal Value
10–19 years old160,352.948,911.1 **
255,316.744,951.2
3110,014.0 *40,079.9
4104,977.8 *36,120.0
20–39 years old1174,417.1 ***189,681.2 ***
2195,349.7 ***146,467.1 ***
3100,410.3251,470.1 ***
4121,342.9 **208,256.0 ***
40–49 years old1109,392.9 ***165,373.6 ***
2106,330.2 ***177,323.1 ***
3107,379.3 *154,520.5 **
4104,316.6 *166,470.0 **
50 years and older1134,981.9 ***188,648.4 ***
2130,486.4 ***154,434.0 ***
3130,544.6 ***141,297.7 ***
4126,049.2 ***107,083.3 **
Notes: *** p < 0.01, ** p < 0.05, * p < 0.1. Case 1: Predicted value when applying the effect of working if the caregiver is working. Case 2: Predicted value when applying the effect of being a “potential full-time caregiver” when caregiver is working. Case 3: Predicted value when applying the effect of working when the caregiver is a “potential full-time caregiver”. Case 4: Predicted value when applying the effect as a “potential full-time caregiver” when the caregiver is a “potential full-time caregiver”.
Table 4. Regression results for HbA1c (males).
Table 4. Regression results for HbA1c (males).
Model 4Model 5
VariablesHbA1cHbA1c
Household income3.72 × 10–129.12 × 10–10
(2.62 × 10–8)(2.50 × 10–8)
Onset timing
0–9 years old–0.210–0.276
(0.415)(0.379)
10–19 years old0.2480.182
(0.340)(0.328)
20–29 years old–0.405–0.405
(0.301)(0.286)
30–49 years old–0.0212–0.00232
(0.294)(0.277)
50 years and older0.2500.152
(0.355)(0.314)
Frequency of outpatient visits
Once or a few times per week/month–0.229–0.224
(0.284)(0.278)
Once or a few times per year0.2580.274
(0.289)(0.284)
Complications
One complication–0.662 **–0.630 **
(0.258)(0.250)
Two or more complications0.4250.434
(0.381)(0.376)
Time discount rate
–5–0%–0.912 ***–0.912 ***
(0.286)(0.277)
2–6%–0.645 **–0.615 **
(0.285)(0.278)
10%–0.474 *–0.458 *
(0.284)(0.276)
20%–0.554 *–0.552 *
(0.310)(0.303)
“potential full-time caregiver” (reference:50 years and older and working caregiver)
“potential full-time caregiver” dummy –0.324 *
(0.195)
10–19 years old and working caregiver–1.299
(0.997)
10–19 years old and “potential full-time caregiver”–1.206
(1.006)
20–39 years old and working caregiver0.0241
(0.346)
20–39 years old and “potential full-time caregiver”–0.241
(0.551)
40–49 years old and working caregiver0.124
(0.299)
40–49 years old and “potential full-time caregiver”–0.135
(0.363)
50 years and older and working caregiver0
(0)
50 years and older and “potential full-time caregiver”–0.480
(0.315)
Government aid1.754 *0.632 *
(0.940)(0.373)
Constant7.955 ***7.988 ***
(0.334)(0.280)
Observations205205
R-squared0.1600.145
Prob > F0.05650.0152
Standard errors in parentheses
*** p < 0.01, ** p < 0.05, * p < 0.1.
Table 5. Regression results for HbA1c (females).
Table 5. Regression results for HbA1c (females).
Model 6Model 7
VariablesHbA1cHbA1c
Household income–6.31 × 10–9–6.11 × 10–9
(1.25 × 10–8)(1.25 × 10–8)
Onset timing
0–9 years old0.3620.401
(0.293)(0.287)
10–19 years old0.511 *0.504 *
(0.271)(0.266)
20–29 years old0.02530.0194
(0.247)(0.248)
30–49 years old0.540*0.453
(0.314)(0.280)
50 years and older0.338–0.00839
(0.401)(0.300)
Frequency of outpatient visits
Once or a few times per week/month–0.803 **–0.793 **
(0.310)(0.311)
Once or a few times per year–0.502 **–0.477 **
(0.218)(0.214)
Complications
One complication0.2070.207
(0.266)(0.260)
Two or more complications0.636 *0.691 **
(0.362)(0.347)
Time discount rate
–5–0%0.2500.246
(0.234)(0.235)
2–6%0.2040.134
(0.252)(0.249)
10%0.2250.179
(0.236)(0.233)
20%0.06190.0985
(0.214)(0.209)
“potential full-time caregiver” (reference: 50 years and older * working caregiver)
Full- time dummy 0.121
(0.223)
10–19 years old and working caregiver–1.309
(0.864)
10–19 years old and “potential full-time caregiver”–0.598
(0.867)
20–39 years old and working caregiver0.184
(0.321)
20–39 years old and “potential full-time caregiver”0.987*
(0.551)
40–49 years old and working caregiver0.216
(0.292)
40–49 years old and “potential full-time caregiver”–0.183
(0.606)
50 years and older and working caregiver0
(0)
50 years and older and “potential full-time caregiver”–0.348
(0.382)
Government aid1.403 *0.116
(0.785)(0.283)
Constant6.811 ***6.974 ***
(0.355)(0.239)
Observations205205
R-squared0.1960.153
Prob > F0.00640.0092
Standard errors in parentheses
*** p < 0.01, ** p < 0.05, * p < 0.1.
Table 6. Marginal effect on HbA1c of care dummy by age range.
Table 6. Marginal effect on HbA1c of care dummy by age range.
MaleFemale
CaseMarginal ValueMarginal Value
10–19 years old17.97 ***7.33 ***
27.73 ***7.19 ***
37.64 ***8.04 ***
47.41 ***7.90 ***
20–39 years old17.27 ***7.22 ***
27.41 ***7.40 ***
36.94 ***8.02 ***
47.09 ***8.20 ***
40–49 years old17.38 ***7.35 ***
27.39 ***7.15 ***
37.06 ***6.95 ***
47.06 ***6.75 ***
50 years and older17.33 ***7.09 ***
27.54 ***7.10 ***
37.01 ***6.74 ***
47.22 ***6.75 ***
Notes: *** p < 0.01. Case 1: Predicted value when applying the effect of working if the caregiver is working. Case 2: Predicted value when applying the effect of being a “potential full-time caregiver” when caregiver is working. Case 3: Predicted value when applying the effect of working when the caregiver is a “potential full-time caregiver”. Case 4: Predicted value when applying the effect as a “potential full-time caregiver” when the caregiver is a “potential full-time caregiver”.
Table 7. Marginal effect on HbA1c of care dummy by age range and government aid.
Table 7. Marginal effect on HbA1c of care dummy by age range and government aid.
MaleFemale
Marginal ValueMarginal Value
10–19 years old16.11 ***6.01 ***
26.00 ***6.64 ***
37.87 ***7.41 ***
47.75 ***8.04 ***
20–39 years old17.28 ***7.22 ***
27.14 ***8.20 ***
39.03 ***8.62 ***
48.90 ***9.60 ***
40–49 years old17.48 ***7.35 ***
27.21 ***6.75 ***
39.23 ***8.75 ***
48.96 ***8.15 ***
50 years and older17.32 ***7.09 ***
27.07 ***6.75 ***
39.07 ***8.49 ***
48.82 ***8.15 ***
Total age17.21 ***7.23 ***
26.97 ***7.32 ***
38.96 ***7.35 ***
48.72 ***7.44 ***
Notes: *** p < 0.01. Case 1: Predicted value when applying the effect of a caregiver working in the absence of government aid. Case 2: Predicted value when the effect of the caregiver being a “potential full-time caregiver” is applied in the absence of government aid. Case 3: Predicted value when the effect of the caregiver working is applied in the presence of government aid. Case 4: Predicted value when caregiver is a “potential full-time caregiver” in the absence of government aid.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sakoda, S. Full-Time or Working Caregiver? A Health Economics Perspective on the Supply of Care for Type 1 Diabetes Patients. Int. J. Environ. Res. Public Health 2022, 19, 1629. https://doi.org/10.3390/ijerph19031629

AMA Style

Sakoda S. Full-Time or Working Caregiver? A Health Economics Perspective on the Supply of Care for Type 1 Diabetes Patients. International Journal of Environmental Research and Public Health. 2022; 19(3):1629. https://doi.org/10.3390/ijerph19031629

Chicago/Turabian Style

Sakoda, Sayaka. 2022. "Full-Time or Working Caregiver? A Health Economics Perspective on the Supply of Care for Type 1 Diabetes Patients" International Journal of Environmental Research and Public Health 19, no. 3: 1629. https://doi.org/10.3390/ijerph19031629

APA Style

Sakoda, S. (2022). Full-Time or Working Caregiver? A Health Economics Perspective on the Supply of Care for Type 1 Diabetes Patients. International Journal of Environmental Research and Public Health, 19(3), 1629. https://doi.org/10.3390/ijerph19031629

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop